{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:31:21Z","timestamp":1767148281806,"version":"build-2238731810"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital Research Fund","award":["BCMC15YH10"],"award-info":[{"award-number":["BCMC15YH10"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.lungcan.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T18:28:10Z","timestamp":1553020090000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors"],"prefix":"10.1016","volume":"132","author":[{"given":"Guk Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heejung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sook","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taejung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Jung","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lungcan.2019.03.016_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ctrv.2012.11.005","article-title":"Thymoma and thymic carcinoma in the target therapies era","volume":"39","author":"Lamarca","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"4","key":"10.1016\/j.lungcan.2019.03.016_bib0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2019.03.016_bib0015","first-page":"173","article-title":"Thymic neoplasm: a rare disease with a complex clinical presentation","volume":"5","author":"Rashid","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"36","key":"10.1016\/j.lungcan.2019.03.016_bib0020","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"10.1016\/j.lungcan.2019.03.016_bib0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11748-012-0160-x","article-title":"Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies","volume":"60","author":"Omatsu","year":"2012","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"20","key":"10.1016\/j.lungcan.2019.03.016_bib0035","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2019.03.016_bib0040","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"5","author":"Girard","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"19","key":"10.1016\/j.lungcan.2019.03.016_bib0045","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1158\/1078-0432.CCR-07-1118","article-title":"Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors","volume":"13","author":"Haluska","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2019.03.016_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2014.00010","article-title":"The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells","volume":"5","author":"Malaguarnera","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.lungcan.2019.03.016_bib0060","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.3390\/cancers3033029","article-title":"Dual targeting of the insulin-like growth factor and collateral pathways in Cancer: combating drug resistance","volume":"26","author":"Ludwig","year":"2011","journal-title":"Cancers."},{"issue":"20","key":"10.1016\/j.lungcan.2019.03.016_bib0065","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/djt263","article-title":"Combating resistance to anti-IGFR antibody by targeting the integrin beta3-Src pathway","volume":"105","author":"Shin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0070","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1038\/ncomms9499","article-title":"STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody","volume":"6","author":"Lee","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lungcan.2017.03.019","article-title":"CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies","volume":"108","author":"Remon","year":"2017","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2019.03.016_bib0080","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/annonc\/mds147","article-title":"Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas","volume":"23","author":"Mimae","year":"2012","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2019.03.016_bib0085","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1007\/s13277-016-5176-x","article-title":"The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies","volume":"37","author":"Motallebnezhad","year":"2016","journal-title":"Tumour Biol."},{"issue":"41","key":"10.1016\/j.lungcan.2019.03.016_bib0090","doi-asserted-by":"crossref","first-page":"43540","DOI":"10.18632\/oncotarget.6183","article-title":"Molecular and functional interactions between AKT and SOX2 in breast carcinoma","volume":"6","author":"Schaefer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2019.03.016_bib0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/modpathol.2012.139","article-title":"Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract","volume":"26","author":"Kitamura","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0100","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/labinvest.2011.140","article-title":"SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity","volume":"91","author":"Nakatsugawa","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.lungcan.2019.03.016_bib0105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bjc.6603696","article-title":"Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy","volume":"96","author":"Schmitz","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"50","key":"10.1016\/j.lungcan.2019.03.016_bib0110","doi-asserted-by":"crossref","first-page":"82511","DOI":"10.18632\/oncotarget.12733","article-title":"IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process","volume":"7","author":"Le Coz","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.lungcan.2019.03.016_bib0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-014-1660-0","article-title":"SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness","volume":"140","author":"Tian","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2019.03.016_bib0120","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3892\/or.2014.3120","article-title":"SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K\/Akt\/mTOR pathway","volume":"31","author":"Yang","year":"2014","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2019.03.016_bib0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10238-010-0127-0","article-title":"SOX2 gene expression in normal human thymus and thymoma","volume":"11","author":"Cimpean","year":"2011","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2019.03.016_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cllc.2013.12.006","article-title":"Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer","volume":"15","author":"Kim","year":"2014","journal-title":"Clin. Lung Cancer"}],"updated-by":[{"DOI":"10.1016\/j.lungcan.2019.07.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000}}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219303721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219303721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:24:47Z","timestamp":1759235087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500219303721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"alternative-id":["S0169500219303721"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.03.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}